Helen S. Kim

Former Chief Business Officer at NGM Biopharmaceuticals, Inc.

Helen S. Kim

Helen S. Kim

Former Chief Business Officer at NGM Biopharmaceuticals, Inc.

Overview
Career Highlights

Kosan Biosciences, Inc.
TRF Pharma, Inc.

RelSci Relationships

804

Number of Boards

10

Birthday

1963

Age

57

Contact Data
Trying to get in touch with Helen S. Kim? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Helen S. Kim likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Exicure Operating Co.

Relationship likelihood: Strong

Co-Founder at Quanterix Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at Angion Biomedica Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at ForSight VISION4, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Exicure Operating Co.

Relationship likelihood: Strong

Associate Professor of Urology at Northwestern University - Feinberg School of Medicine

Relationship likelihood: Strong

Founder at The Column Group LLC

Relationship likelihood: Strong

Former Founder & Director at Peloton Therapeutics, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Exicure Operating Co.

Relationship likelihood: Strong

Co-Founder, Chairman at Exicure, Inc.

Relationship likelihood: Strong

Paths to Helen S. Kim
Potential Connections via
Relationship Science
You
Helen S. Kim
Former Chief Business Officer at NGM Biopharmaceuticals, Inc.
Education
B.S. in Chemical Engineering
Class of 1985
Career History
Chief Business Officer
2009 - 2012

NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.

President & Chief Executive Officer
2007 - 2008

Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY.

Senior Vice President, Corporate Development
1999 - 2002

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. At Onyx, we are grounded in three leadership hallmarks that guide how we manage our business and build value for patients and shareholders: innovation, patient-centeredness and stewardship.

Boards & Committees
Director
Prior
Director
Prior
Transactions
Details Hidden

NGM Biopharmaceuticals, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Helen S. Kim. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Helen S. Kim's profile does not indicate a business or promotional relationship of any kind between RelSci and Helen S. Kim.